Therapeutic area: Cardiology/Vascular Disease

Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?

September 15, 2020

Quelles sont les considerations de traiter la coronopathie au-delà de l'AAS? Est-ce le temps d'établir un nouveau standard?

Dispelling myths in AF: Managing the challenges of elderly, frail and/or renally impaired patients

An Approach to the Treatment of AF and CV Disease in These Challenging Times

How to Reduce the Risk of Major Cardiovascular and Limb Events in the CAD + PAD Patients

Hot Topics in Vascular Protection for the CAD Patient and AF Patient

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?

February 13, 2020

Optimizing Heart Failure Therapy - The Time is Now: Putting Evidence into Practice

December 5, 2019

15 min. Highlights from The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?

October 26, 2019

Women and CV Disease: Closing Care Gaps & Assessing Risk